Cancer Research UK
{{Short description|Cancer research and awareness charity}}
{{Use dmy dates|date=April 2022}}
{{Infobox organization
| name = Cancer Research UK
| image = Cancer Research UK.svg
| type = Charitable organisation
| founded_date = {{Start date|2002|02|04|df=y}}
| vat_id =
| registration_id = {{plainlist|
- England and Wales: 1089464
- Scotland: SC041666
- Isle of Man: 1103
}}
| founder =
| location = 2 Redman Place London E20 1JQ
| coordinates = {{Coord|51.5426|-0.0119}}
| origins =
| key_people = Michelle Mitchell (CEO)
Charles Swanton (Chief Clinician)
Ketan J. Patel (Chief Scientist)
| area_served =
| product =
| mission =
| focus = Cancer research
Health policy
| method =
| revenue = £719 million (2022/23){{EW charity|1089464}}
| endowment =
| num_volunteers = 25,000 (2023)
| num_members =
| subsid =
| owner =
| leader_title = Patron
| leader_name = The King
| former name = {{Nowrap|Imperial Cancer Research Fund (ICRF)
The Cancer Research Campaign (CRC)}}
| homepage = {{URL|https://www.cancerresearchuk.org}}
| dissolved =
| website = https://www.cancerresearchuk.org/
| footnotes =
}}
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation.{{cite news|url=http://news.bbc.co.uk/1/hi/health/1703612.stm |title=Cancer charity mega-merger | work=BBC News | date=11 December 2001}}{{cite web|title=The Top 500 Charities |url=http://www.charitiesdirect.com/charities/top500.php |publisher=www.charitiesdirect.com |access-date=10 July 2015 |url-status=dead |archive-url=https://web.archive.org/web/20090302161743/http://www.charitiesdirect.com/charities/top500.php |archive-date=2 March 2009 }} It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.{{cite web |url=http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/@abt/@gen/documents/generalcontent/cr_075236.pdf |title=Annual Report and Accounts |date=11 December 2001 |access-date=4 April 2011 |url-status=dead |archive-url=https://web.archive.org/web/20120428031840/http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/%40abt/%40gen/documents/generalcontent/cr_075236.pdf |archive-date=28 April 2012 }}[http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/@abt/@gen/documents/generalcontent/cr_043577.pdf] Report on 2008/9 research activities {{webarchive|url=https://web.archive.org/web/20110725134828/http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/%40abt/%40gen/documents/generalcontent/cr_043577.pdf|date=25 July 2011}}[http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/@abt/@gen/documents/generalcontent/cr_075376.pdf] Annual Review 2010/11 {{webarchive|url=https://web.archive.org/web/20120504194150/http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/%40abt/%40gen/documents/generalcontent/cr_075376.pdf|date=4 May 2012}}
The organisation's work is almost entirely funded by the public. It raises money through donations, legacies, community fundraising, events, retail and corporate partnerships. Over 25,000 people are regular volunteers.
History
The Imperial Cancer Research Fund (ICRF) was founded in 1902 as the Cancer Research Fund, changing its name to the Imperial Cancer Research Fund in 1904. It grew over the next twenty years to become one of the world's leading cancer research charities. Its executive committee was chaired by Sir William Church from its inception in 1902 until 1923.{{cite web|title=Sir William Selby Church|website=Royal College of Physicians of London|url=https://history.rcplondon.ac.uk/inspiring-physicians/sir-william-selby-church}} Its flagship laboratories formerly at Lincoln's Inn Fields, London, and Clare Hall, Hertfordshire, and known as the Cancer Research UK London Research Institute, are now part of the Francis Crick Institute.
The British Empire Cancer Campaign (BECC) was founded in 1923, and initially drew a hostile response from ICRF and the Medical Research Council, who considered it a rival.Austoker, Joan. A history of the Imperial Cancer Research Fund, 1902-1986. Oxford University Press, 1988.[http://www.aim25.ac.uk/cats/20/4605.htm Cancer Research Campaign formerly British Empire Cancer Campaign] {{Webarchive|url=https://web.archive.org/web/20160303220044/http://www.aim25.ac.uk/cats/20/4605.htm |date=3 March 2016 }}, 1923-1981. Wellcome Library Archive. Retrieved 1 February 2011 "The Campaign", as it was colloquially known, became a very successful and powerful grant-giving body. In 1970, the charity was renamed The Cancer Research Campaign (CRC).
Incorporated on 20 November 2001,{{Cite web |title=Cancer Research UK: overview |url=https://find-and-update.company-information.service.gov.uk/company/04325234 |access-date=2022-03-26 |website=Companies House UK.GOV |language=en}} the two organisations officially merged on 4 February 2002 to form Cancer Research UK, the largest independent cancer research organisation in the world (the largest, the National Cancer Institute, is funded by the US Government).[https://www.theguardian.com/society/2002/feb/04/charities.charitymanagement World's biggest cancer charity formed], The Guardian, 4 February 2002.{{cite journal |title=Cancer Research UK |journal=Nat. Cell Biol. |volume=4 |issue=3 |pages=E45 |date=March 2002 |pmid=11875441 |doi=10.1038/ncb0302-e45 |doi-access=free }} At the time of the merger, the ICRF had an annual income of £124m, while the CRC had an income of £101m.
Based on article share during the period between January 2015 to August 2019, Nature listed Cancer Research UK in the top 150 of the Top 200 institutions in cancer research in the world.{{Cite web |title=Top 200 institutions in cancer research {{!}} Nature Index 2020 Cancer |url=https://www.natureindex.com/supplements/nature-index-2020-cancer/tables/overall |access-date=2022-03-26 |website=Nature |language=en}}
CRUK had an income of £718,793,138 and expenditure of £640,845,146 for the financial year ending in 31 March 2023.{{Cite web |title=CANCER RESEARCH UK - Charity 1089464 |url=https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/3987102/charity-overview |access-date=2022-03-26 |website=Register of Charities, Charity Commission of England and Wales |language=en-GB}}
On 30 April 2024, King Charles III was announced as patron of the charity.{{Cite web |date=2024-04-30 |title=His Majesty King Charles III announced as new patron of Cancer Research UK |url=https://news.cancerresearchuk.org/2024/04/30/king-charles-iii-new-patron-of-cancer-research-uk/ |access-date=2024-04-30 |website=Cancer Research UK - Cancer News |language=en-GB}}
Research
File:cmglee Cambridge Cancer Research.jpgIn the financial year 2014/15, the charity spent £422.67 million on cancer research projects (67% of its total income for that year). The bulk of the remaining costs were spent on trading and fundraising costs with a small amount spent on information services, campaigning, advocacy, administration and other activities or was held in reserve.
Around 40% of its research expenditure (27% of its total spending) is on basic laboratory research into the molecular basis of cancer.{{cite web |url=http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/5-year-strategy/ |title=Cancer Research UK: Our strategy 2009-2014 |publisher=Aboutus.cancerresearchuk.org |access-date=4 April 2011 |url-status=dead |archive-url=https://web.archive.org/web/20100710104311/http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/5-year-strategy/ |archive-date=10 July 2010 }} The remainder supports research into over 100 specific cancer types, focusing on drug discovery and development; prevention, early detection and imaging; surgery and radiotherapy; and cancers where survival rates are still low, such as oesophageal, lung and pancreatic cancers.{{cite web | url=http://www.cancerresearchuk.org/about-us/how-we-are-run/annual-report-and-accounts | title=Annual Report and Accounts| date=11 September 2014}}
The charity funds the work of over 4,000 researchers, doctors and nurses throughout the UK, supports over 200 clinical trials and studies cancer and cancer risk in over a million people in the UK.{{cite web|date=31 March 2011|title=Cancer Research UK: What we do|url=http://web-archive-sources.org/cr_075236.pdf|url-status=usurped|archive-url=https://web.archive.org/web/20141111111234/http://web-archive-sources.org/cr_075236.pdf|archive-date=11 November 2014|access-date=4 April 2011|publisher=Aboutus.cancerresearchuk.org}}
= Research institutes =
- The [https://www.beatson.gla.ac.uk/ Cancer Research UK Scotland Institute] (formerly the Cancer Research UK Beatson Institute), which sits within the University of Glasgow and has ties to the Beatson West of Scotland Cancer Centre
- The Cancer Research UK Cambridge Institute, which sits within the University of Cambridge close to Addenbrooke's Hospital on the Cambridge Biomedical Campus.
- The [https://www.cruk.manchester.ac.uk/ Cancer Research UK Manchester Institute], formerly the Paterson Institute for Cancer Research, which sits within the University of Manchester and has ties to the Christie Hospital.{{cite web|title=Welcome to the Cancer Research UK Manchester Institute|url=http://www.cruk.manchester.ac.uk/|publisher=University of Manchester|access-date=11 November 2015}}{{cite web|url=https://www.cancerresearchuk.org/funding-for-researchers/how-we-deliver-research/our-institutes |title=Our institutes |publisher=Cancer Research UK |date=20 June 2017 |access-date=16 June 2018}}
= Partnerships =
- The Francis Crick Institute, with the Medical Research Council and the Wellcome Trust
- The Oxford Institute for Radiation Oncology, with the Medical Research Council
- The Gurdon Institute, with the Wellcome Trust
- The Manchester Cancer Research Centre, formed in 2006 by the University of Manchester, Cancer Research UK, and the Christie NHS Foundation Trust.{{cite web|title=Reaarch Beacons: Cancer|url=http://www.manchester.ac.uk/research/beacons/cancer/|publisher=University of Manchester|access-date=11 November 2015}}
- National Cancer Research Institute which also includes the Medical Research Council (UK) and Blood Cancer UK.{{cite book|last=Rafi|first=Imran|url=https://books.google.com/books?id=gs48jpOzo8oC&pg=PA12|title=An Introduction to the Use of Anticancer Drugs|date=4 January 2006|publisher=Elsevier Health Sciences|isbn=978-0-7506-8830-7|page=12|access-date=31 January 2011}}
- UK Department of Health, the Wellcome Trust, the National Health Service, NICE, and the Public Health England National Cancer Registration and Analysis Service.{{cite web|date=21 June 2010|title=Project Press Release|url=http://www.ukcmri.ac.uk/press/press_release5.html|url-status=dead|archive-url=https://web.archive.org/web/20100624083615/http://www.ukcmri.ac.uk/press/press_release5.html|archive-date=24 June 2010|access-date=11 August 2010|publisher=UK Centre for Medical Research and Innovation web site}}
= Citizen-science projects =
The charity participates in numerous citizen-science projects including:
- Cell Slider – its first project set up in 2012. Samples of breast cancer tumours, taken from earlier studies, were analysed through a web-based application.
- Play to Cure: Genes in Space – its first mobile game developed with Guerilla Tea, which originated as a prototype during a 48-hour game jam. Players plot routes to guide a spaceship in-game, which corresponds to analysis of genetic data.{{cite journal | last=Coburn | first=Cassandra | title=Play to Cure: Genes in Space | journal=The Lancet Oncology | publisher=Elsevier BV | volume=15 | issue=7 | year=2014 | issn=1470-2045 | doi=10.1016/s1470-2045(14)70259-1 | page=688}}{{Cite news|url=https://www.reuters.com/article/us-cancer-game-idUSBREA130P320140204|title=Citizens seek cancer cure with 'Genes in Space' smartphone game|date=4 February 2014|work=Reuters|first=Kate|last=Kelland|access-date=9 October 2021|language=en}}
- Reverse the Odds – a mobile game based upon 'Play to Cure: Genes in Space' but with greater accuracy, involved completing puzzles and answering questions on lung and bladder cancer samples.
- The Impossible Line – a mobile puzzle game spotting genetic faults in breast cancer data, provided evidence that the game aspect lowered accuracy.
- Trailblazer – a web-based application looking at tissue samples identifying the presence or absence of cancer cells.{{Cite news|url=http://www.cancerresearchuk.org/support-us/citizen-science/the-projects#citizenscience4|title=The projects|date=2 March 2016|newspaper=Cancer Research UK|access-date=14 February 2017|language=en}}
= Research centres =
The charity funds networks in seven locations across the UK, to drive collaborations between universities, NHS hospitals, and other research organisations. Centre status is awarded to locations performing the highest quality cancer research, to provide funds for equipment and training.{{Cite web |date=2014-03-11 |title=Our Research Centres |url=https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centres |access-date=2022-08-18 |website=Cancer Research UK |language=en}} Centre status has been designated to:
- Cambridge: University of Cambridge
- City of London: King's College London, University College London, Barts Cancer Institute, Francis Crick Institute
- Convergence Science: Imperial College London and the Institute of Cancer Research
- Manchester: University of Manchester
- Newcastle: Newcastle University
- Oxford: University of Oxford
- Scotland: University of Edinburgh and University of Glasgow
= Achievements and impact =
Drugs developed by the organisation's scientists include:
- Cisplatin and carboplatin, cytotoxic chemotherapy drugs discovered at the Institute of Cancer Research in London.{{Cite journal |author=Lucy Holmes |url=http://scienceblog.cancerresearchuk.org/2015/08/26/cisplatin-the-story-of-a-platinum-selling-life-saver/ |title=Our milestones: Cisplatin – the story of a platinum-selling life-saver – Cancer Research UK – Science blog |journal=Chemico-Biological Interactions |volume=5 |issue=6 |pages=415–24 |date=26 August 2015 |doi=10.1016/0009-2797(72)90078-6 |access-date=16 June 2018 |pmid=4652593 |archive-date=16 June 2018 |archive-url=https://web.archive.org/web/20180616153650/http://scienceblog.cancerresearchuk.org/2015/08/26/cisplatin-the-story-of-a-platinum-selling-life-saver/ |url-status=dead }}
- Abiraterone, a prostate cancer drug discovered at the Institute of Cancer Research in London.{{Cite journal|url=http://scienceblog.cancerresearchuk.org/2011/09/21/where-did-abiraterone-come-from/|title=Where did abiraterone come from?|volume=38|issue=13|pages=2463–71|author=Scowcroft H|date=21 September 2011|journal=Science Update Blog|access-date=28 September 2011|archive-date=25 September 2011|archive-url=https://web.archive.org/web/20110925093704/http://scienceblog.cancerresearchuk.org/2011/09/21/where-did-abiraterone-come-from/|url-status=dead}}
- Temozolomide, which has an effect on glioblastoma, discovered by CRUK scientists at the University of Aston.{{cite web|url=https://www.cancerresearchuk.org/funding-for-researchers/research-features/2017-07-26-temozolomide-the-brain-tumour-superstar |title=Temozolomide: the brain tumour superstar |publisher=Cancer Research UK |date=26 July 2017 |access-date=16 June 2018}}
- Rucaparib, a PARP inhibitor drug discovered by CRUK scientists including Ruth Plummer at the Northern Institute for Cancer Research .{{cite web|url=https://www.cancerresearchuk.org/funding-for-researchers/research-features/2017-07-21-rucaparib-targeting-dna-repair-and-a-patients-perpective |title=Rucaparib: targeting DNA repair and a patient's perspective |publisher=Cancer Research UK |date=21 July 2017 |access-date=16 June 2018}}
- Tamoxifen, a hormone therapy used to treat breast cancer and lower the risk of recurrence.{{Cite web|url=https://scienceblog.cancerresearchuk.org/2012/10/15/high-impact-science-tamoxifen-the-start-of-something-big/|title=Tamoxifen – the start of something big|website=Cancer Research UK – Science blog|date=15 October 2012|access-date=8 October 2019|archive-date=7 December 2019|archive-url=https://web.archive.org/web/20191207142557/https://scienceblog.cancerresearchuk.org/2012/10/15/high-impact-science-tamoxifen-the-start-of-something-big/|url-status=dead}}
Several of the organisation's scientists have won major prizes, including:
- Tomas Lindahl: one of three recipients of the 2015 Nobel Prize in Chemistry, for mechanistic studies of DNA repair,{{Cite news|url=https://www.nytimes.com/2015/10/08/science/tomas-lindahl-paul-modrich-aziz-sancarn-nobel-chemistry.html|title=Nobel Prize in Chemistry Awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for DNA Studies|last=Broad|first=William J.|date=7 October 2015|newspaper=The New York Times|access-date=7 October 2015|issn=0362-4331}}{{cite news|url=https://www.nobelprize.org/nobel_prizes/chemistry/laureates/2015/popular-chemistryprize2015.pdf|title=The Nobel Prize in Chemistry 2015 – DNA repair – providing chemical stability for life|author=Staff|date=7 October 2015|work=Nobel Prize|access-date=7 October 2015}} joined the organisation as a researcher in 1981, and from 1986 was the first Director of their Clare Hall research institute in Hertfordshire, since 2015 part of the Francis Crick Institute.
- Paul Nurse and Tim Hunt: recipients of the 2001 Nobel Prize in Physiology or Medicine, for work started at the London Research Institute.[https://www.nobelprize.org/nobel_prizes/medicine/laureates/2001/ The Nobel Prize in Physiology or Medicine 2001]. Nobelprize.org.
- Renato Dulbecco: recipient of the 1975 Nobel Prize in Physiology or Medicine, while deputy director of what was then the Imperial Cancer Research Fund.{{cite web|author=Kathy Weston |url=http://scienceblog.cancerresearchuk.org/2015/10/05/counting-lumps-in-the-lawn-a-look-back-at-the-1975-nobel-prize/ |title=Counting lumps in the lawn: a look back at the 1975 Nobel Prize – Cancer Research UK – Science blog |publisher=Scienceblog.cancerresearchuk.org |date=5 October 2015 |access-date=16 June 2018}}
Other charitable activities
= Information services =
Through Cancer Health UK, a website written in Plain English, it provides information on cancer and cancer care, and a unique clinical trials database.{{cite book|last1=Gaze|first1=Mark N.|last2=Wilson|first2=Isobel M.|title=Handbook of Community Cancer Care|url=https://books.google.com/books?id=EBEEtOD1TMMC&pg=PT272|access-date=31 January 2011|date=15 July 2002|publisher=Cambridge University Press|isbn=978-1-84110-001-2|page=272}} A team of nurses provides a confidential telephone service, the Cancer Chat forum provides a place for users to talk to others affected by cancer, and mobile cancer awareness units deliver health information to locations of high cancer incidence and mortality. It provides statistical information via the Cancer Stats section. It also provides publications for the public to order and download.
Cancer Research UK publishes a twice-monthly professional medical journal, the British Journal of Cancer.{{Cite web |title=Journal Information {{!}} British Journal of Cancer |url=https://www.nature.com/bjc/journal-information |access-date=2024-08-17 |website=www.nature.com |language=en}}
= Influencing public policy =
The charity worked to bring about the smoking ban in England and continues to campaign for further action on smoking.{{cite news|title=Chief medic considered quitting|url=http://news.bbc.co.uk/2/hi/uk_news/politics/4466176.stm|access-date=1 February 2011|newspaper=BBC News|date=24 November 2005}} The charity lobbies for better screening programmes and advises on access to new cancer medicines.
Sources of funding
File:BCPcrukBristolopening027x(1).jpg.]]
Income sources include:
- Individual donations, regular giving and philanthropy, raising £191 million in 2019/20.{{Cite web|url=https://www.cancerresearchuk.org/about-us/our-organisation/how-we-spend-your-money|title = How we spend your money|date = 13 July 2020}}
- Legacies from wills, raising £184 million in 2019/20.
- Royalties and grants from licensing its intellectual property, such as for the drug abiraterone, generating £118 million in 2019/20.
- Public participation fundraising events such as Race for Life, Stand Up to Cancer UK and a one off Race Against Cancer, raising £48 million in 2019/20.
- Around 600 charity shops selling new and donated second-hand goods,{{Cite web|url=https://www.cancerresearchuk.org/get-involved/ways-to-shop|title = Ways to shop|date = 26 October 2016}} generating £10 million profit in 2019/20.
On 18 July 2012, it was announced that Cancer Research UK was to receive its largest single donation of £10 million from an anonymous donor. The money went towards the £100 million funding for the Francis Crick Institute in London.{{cite news| date = 18 July 1012 | newspaper = Cambridge News | title = Cancer Research UK is handed £10m}}
During the COVID-19 pandemic in 2020, CRUK closed its shops and cancelled mass participation fundraising events. They predicted that this, coupled with economic uncertainty affecting people's ability or willingness to donate, would lead to a 30% fall in income that year and a reduction in income lasting at least 3 years.{{Cite web|url=https://www.theguardian.com/society/2020/jul/21/michelle-mitchell-cuts-to-uk-cancer-research-could-have-a-huge-impact-on-patients|title=Michelle Mitchell: 'Cuts to UK cancer research could have a huge impact on patients'|website=TheGuardian.com |date=21 July 2020}}
Criticism
In June 2011, Cancer Research UK was one of several health charities (along with the British Heart Foundation, the Alzheimer's Society and Parkinson's UK) targeted by the animal rights organisation Animal Aid in a series of advertisements in British newspapers urging members of the public to stop giving donations to organisations that fund medical research involving animal experiments.{{cite news|url=https://www.independent.co.uk/news/uk/home-news/animal-rights-group-declares-war-on-leading-health-charities-2300281.html|title=Animal rights group declares war on leading health charities|access-date=9 July 2011|work=The Independent|date=21 June 2011|location=London|first=Oliver|last=Wright}}{{cite news| url=http://news.scotsman.com/science/Charities-are--attacked-over.6788444.jp | title=Charities are attacked over experiments | location=Edinburgh | work=The Scotsman | date=20 June 2011}}
In April 2017, the Information Commissioner's Office fined eleven charities that breached the Data Protection Act by misusing donors’ personal data. Cancer Research UK was fined £16,000.{{cite web |url=https://ico.org.uk/about-the-ico/news-and-events/news-and-blogs/2017/04/ico-fines-eleven-more-charities/ |title=ICO fines eleven more charities |publisher=ICO |date=5 April 2017 |access-date=9 October 2021 |archive-date=13 August 2017 |archive-url=https://web.archive.org/web/20170813221413/https://ico.org.uk/about-the-ico/news-and-events/news-and-blogs/2017/04/ico-fines-eleven-more-charities/ |url-status=dead }}
See also
References
{{Reflist|2}}
External links
{{Commons category}}
- {{EW charity|1089464}}
- {{Scottish charity|SC041666}}
- [http://www.cancerresearchuk.org/cancer-help/ CancerHelp UK]
- [http://www.cruk.org/cancerstats CancerStats]
- [https://cancerchat.cancerresearchuk.org/ Cancer Chat Forum]
- [http://www.cancerresearchuk.org/leaflets Download site for leaflets]
{{Francis Crick Institute}}
{{Authority control}}
{{DEFAULTSORT:Cancer Research Uk}}
Category:Cancer organisations based in the United Kingdom
Category:Health charities in the United Kingdom
Category:Health in the London Borough of Newham
Category:Organisations based in the London Borough of Newham
Category:Research institutes established in 2002